Last updated: May 4, 2026
Sponsor: HITEC-Institute of Medical Sciences
Overall Status: Completed
Phase
1
Condition
Polycystic Ovarian Syndrome
Reproductive Health
Treatment
Clomiphene Citrate and letrozole
Clinical Study ID
NCT06813118
HITECIMSTAXILLA
Ages 20-40 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- women of 20-40 years with a history of PCOS and resistant to CC
Exclusion
Exclusion Criteria:
Premature ovarian insufficiency
Husband has oligo azoospermia
Hypothyroidism
Hyperprolactinemia
Study Design
Total Participants: 42
Treatment Group(s): 1
Primary Treatment: Clomiphene Citrate and letrozole
Phase: 1
Study Start date:
June 07, 2024
Estimated Completion Date:
March 25, 2025
Study Description
Connect with a study center
HIT Hospital
Rawalpindi, Punjab Province 47080
PakistanSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.